Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maze Therapeutics (MAZE) Return on Sales (2024 - 2026)

Maze Therapeutics' Return on Sales history spans 3 years, with the latest figure at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Sales changed N/A to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.06%, a N/A change, with the full-year FY2024 number at 0.03%, changed N/A from a year prior.
  • Return on Sales hit 0.01% in Q1 2026 for Maze Therapeutics, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for MAZE hit a ceiling of 0.01% in Q2 2024 and a floor of 0.1% in Q3 2024.
  • Historically, Return on Sales has averaged 0.01% across 3 years, with a median of 0.01% in 2024.
  • The widest YoY moves for Return on Sales: up 11bps in 2025, down 0bps in 2025.
  • Tracing MAZE's Return on Sales over 3 years: stood at 0.0% in 2024, then soared by 326bps to 0.01% in 2025, then tumbled by -246bps to 0.01% in 2026.
  • Business Quant data shows Return on Sales for MAZE at 0.01% in Q1 2026, 0.01% in Q3 2025, and 0.01% in Q2 2025.